Evidence map›Paper›PMID 27556955›Full record

ArticleNuclear medicine and biology2016

Comparison of biological properties of

Zuo-Quan Zhao, Yong Yang, Wei Fang, Shuang Liu

Abstract readComparative Study
In one paragraph

Article in Nuclear medicine and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. EGFR- and Integrin αInternational journal of molecular sciences · 2024
    Review
  2. Review
  3. Evaluation ofThoracic cancer · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Article
  8. [Theranostics of osteosarcoma and lung metastasis with new integrin αZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2019
    Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zuo-Quan ZhaoDepartment of Nuclear Medicine, Fuwai Hospital, the National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yong YangDepartment of Nuclear Medicine, Fuwai Hospital, the National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; School of Health Sciences, Purdue University, West Lafayette, USA.
Wei FangDepartment of Nuclear Medicine, Fuwai Hospital, the National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: nuclearfw@126.com.
Shuang LiuSchool of Health Sciences, Purdue University, West Lafayette, USA. Electronic address: liu100@purdue.edu.

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
Novel 99mTc(III) Complexes as SPECT Radiotracers for MPIR21EB017237 · NIBIB · PURDUE UNIVERSITY · PI LIU, SHUANG · 2013 to 2014
$417k
NCI NIH HHS P30 CA023168NIBIB NIH HHS R21 EB017237
6 · The paper itself

Abstract

introductionThis study sought to evaluate a

methodsHYNIC-4P-RGD

results

conclusionIncreasing peptide multiplicity from 3P-RGD

Indexed as

DimerizationAnimalsCell Line, TumorDrug StabilityGene Expression Regulation, NeoplasticHumansHydrazinesIntegrin alphaVbeta3Isotope LabelingMiceNicotinic AcidsPeptides, CyclicPolymerizationRadioactive TracersRadiochemistrySingle Photon Emission Computed Tomography Computed Tomography6-hydrazinopyridine-3-carboxylic acidcyclic arginine-glycine-aspartic acid peptideHydrazinesIntegrin alphaVbeta3Nicotinic AcidsPeptides, CyclicRadioactive TracersTechnetium(99m)Tc-trimeric cyclic RGD peptideintegrin α(v)β(3)SPECTtumor imaging

Identifiers

PMID27556955
PMCPMC5002266

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.